Page 905 - Veterinary Immunology, 10th Edition
P. 905

azathioprine in infected mink prevents the development of many of
  VetBooks.ir  these lesions and prolongs survival, whereas experimental

               vaccination with inactivated Aleutian disease virus increases the
               severity of infections.



               Equine Infectious Anemia


               This disease is caused by the equine infectious anemia virus (EIAV).
               The disease may be acute, chronic or inapparent. Waves of viremia

               are associated with clinical disease. Following recovery from the
               first attack of disease characterized by anemia, fever,
               thrombocytopenia, weight loss, and depression, horses may remain
               healthy for weeks or months. However, three or four relapses at 2-
               to 8-week intervals may occur before the horse either develops a

               chronic wasting disease or becomes clinically normal. Each episode
               of disease tends to be milder than the previous one. The fevers are
               lower and the anemia less severe. EIAV, like other lentiviruses,

               undergoes random mutation, and new, antigenically different
               variants are produced. The elimination of each variant is
                                                                                    +
               determined initially by the appearance of both CD4  and CD8                       +
               MHC-restricted cytotoxic T cells. Later, as new variants are
               produced, the infected horse makes neutralizing antibodies to that

               variant, and as a result, the viremia ends. Variants of EIAV,
               however, appear rapidly and randomly. The appearance of a new
               non-neutralizable variant leads to a viremic wave and clinical

               relapse. After the virus has undergone several antigenic variations
               and the horse has responded to them all, the neutralizing antibody
               spectrum of the horse's serum becomes very broad, and viremia
               drops to a low level. Large amounts of tissues may then have to be
               examined to isolate the virus.

                  In addition to evading the immune response through antigenic
               variation, EIAV triggers immune-mediated tissue damage. The red
               cells of viremic horses adsorb circulating the virus onto their

               surface. Antibodies and complement then bind to the virus, as a
               result of which the red cells are cleared from the circulation more
               rapidly than normal. Infected horses may also develop a
               glomerulonephritis as a result of immune-complex deposition on
               glomerular basement membranes. Horses infected with EIAV have






                                                         905
   900   901   902   903   904   905   906   907   908   909   910